Multitrace-4 Neonatal Interactions
There are 200 drugs known to interact with Multitrace-4 Neonatal (trace elements), along with 4 disease interactions. Of the total drug interactions, 5 are major, 84 are moderate, and 111 are minor.
Medications known to interact with Multitrace-4 Neonatal
Note: Showing generic names only.
A
- abatacept
- abemaciclib
- abrocitinib
- acarbose
- acetohexamide
- adalimumab
- afamitresgene autoleucel
- albiglutide
- alefacept
- alendronate
- alogliptin
- anakinra
- anifrolumab
- anti-thymocyte globulin (rabbit)
- avacopan
- axicabtagene ciloleucel
- azathioprine
B
- baloxavir marboxil
- baricitinib
- basiliximab
- beclomethasone
- belatacept
- belimumab
- betamethasone
- bexagliflozin
- bimekizumab
- blinatumomab
- brexucabtagene autoleucel
- brodalumab
- budesonide
C
- cabotegravir
- canagliflozin
- canakinumab
- carbonyl iron
- ceftibuten
- cephalexin
- cephradine
- certolizumab
- chlorpropamide
- ciltacabtagene autoleucel
- cinoxacin
- ciprofloxacin
- cortisone
- crovalimab
- cyclosporine
D
- daclizumab
- danicopan
- dapagliflozin
- deferiprone
- deflazacort
- delafloxacin
- demeclocycline
- deucravacitinib
- dexamethasone
- dimethyl fumarate
- diroximel fumarate
- dolutegravir
- dulaglutide
- dupilumab
E
- eculizumab
- efalizumab
- efgartigimod alfa
- eltrombopag
- elvitegravir
- empagliflozin
- enoxacin
- ertugliflozin
- etanercept
- etidronate
- etrasimod
- everolimus
- exenatide
F
G
H
I
- ibandronate
- imetelstat
- infliximab
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- iptacopan
- iron bisglycinate
- iron polysaccharide
- iron protein succinylate
- ixekizumab
L
- leflunomide
- levofloxacin
- lifileucel
- linagliptin
- liraglutide
- lixisenatide
- lomefloxacin
- loncastuximab tesirine
- lurbinectedin
- lymphocyte immune globulin, anti-thy (equine)
M
- metformin
- methylprednisolone
- miglitol
- minocycline
- mirikizumab
- momelotinib
- moxifloxacin
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
N
O
P
- patiromer
- pegcetacoplan
- penicillamine
- pioglitazone
- ponesimod
- pozelimab
- pramlintide
- prednisolone
- prednisone
R
- raltegravir
- ravulizumab
- repaglinide
- rilonacept
- risankizumab
- risedronate
- rosiglitazone
- rozanolixizumab
S
- sarecycline
- sarilumab
- satralizumab
- saxagliptin
- secukinumab
- semaglutide
- siltuximab
- siponimod
- sirolimus
- sirolimus topical
- sitagliptin
- sodium polystyrene sulfonate
- sotagliflozin
- sparfloxacin
- spesolimab
- sutimlimab
T
- tacrolimus
- temsirolimus
- teplizumab
- teriflunomide
- tetracycline
- tildrakizumab
- tiludronate
- tirzepatide
- tocilizumab
- tofacitinib
- tolazamide
- tolbutamide
- treosulfan
- triamcinolone
- trientine
- troglitazone
- trovafloxacin
U
V
Z
Multitrace-4 Neonatal disease interactions
There are 4 disease interactions with Multitrace-4 Neonatal (trace elements) which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Featured
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Reviews & ratings
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.